DTIL (STOCKS)
Precision BioSciences, Inc. Common Stock
$6.210000
+0.110000 (+1.80%)
Prev close: $6.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Amoroso
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $160.10M
- Employees
- 67
- P/E (TTM)
- -1.67
- P/B (TTM)
- 2.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.75 | $-0.67 | -0.0819 | -12.26% |
|
Dec 2025 (Q4)
|
$1.05 | $-0.55 | +1.5957 | +292.41% |
|
Sep 2025 (Q3)
|
$-1.84 | $-1.37 | -0.4732 | -34.62% |
|
Jun 2025 (Q2)
|
$-2.13 | $-1.60 | -0.5320 | -33.29% |
Financial Statements
| Revenues | $45.07M |
| Benefits Costs and Expenses | $88.67M |
| Costs And Expenses | $88.67M |
| Operating Expenses | $84.18M |
| Depreciation and Amortization | $1.37M |
| Research and Development | $53.69M |
| Other Operating Expenses | $29.85M |
| Operating Income/Loss | -$39.11M |
| Income/Loss From Continuing Operations After Tax | -$44.49M |
| Income/Loss From Continuing Operations Before Tax | -$43.60M |
| Income/Loss From Equity Method Investments | -$6.63M |
| Net Income/Loss | -$43.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$43.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.14 |
| Diluted Earnings Per Share | -$2.14 |
| Basic Average Shares | 49,596,868 |
| Diluted Average Shares | 49,596,868 |
| Assets | $143.89M |
| Current Assets | $108.69M |
| Prepaid Expenses | $3.50M |
| Other Current Assets | $105.19M |
| Noncurrent Assets | $35.20M |
| Fixed Assets | $1.18M |
| Intangible Assets | $1.13M |
| Other Non-current Assets | $32.89M |
| Liabilities | $67.79M |
| Current Liabilities | $7.76M |
| Accounts Payable | $944.00K |
| Wages | $1.14M |
| Other Current Liabilities | $5.67M |
| Noncurrent Liabilities | $60.04M |
| Equity | $76.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $76.10M |
| Liabilities And Equity | $143.89M |
| Net Cash Flow From Operating Activities | -$58.73M |
| Net Cash Flow From Operating Activities, Continuing | -$58.73M |
| Net Cash Flow From Investing Activities | -$434.00K |
| Net Cash Flow From Investing Activities, Continuing | -$434.00K |
| Net Cash Flow From Financing Activities | $85.22M |
| Net Cash Flow From Financing Activities, Continuing | $85.22M |
| Net Cash Flow | $26.06M |
| Net Cash Flow, Continuing | $26.06M |
| Comprehensive Income/Loss | -$43.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$43.60M |
| Other Comprehensive Income/Loss | $0.00 |